IARTINTEGRA LIFESCIENCES HOLDIN...

Nasdaq integralife.com


$ 28.32 $ -0.19 (-0.67 %)    

Friday, 24-May-2024 15:59:53 EDT
QQQ $ 454.82 $ 2.58 (0.57 %)
DIA $ 398.57 $ -0.71 (-0.18 %)
SPY $ 530.36 $ 3.51 (0.67 %)
TLT $ 91.26 $ 0.27 (0.3 %)
GLD $ 225.37 $ 0.20 (0.09 %)
$ 28.51
$ 28.28
$ 0.00 x 0
$ 0.00 x 0
$ 27.92 - $ 28.60
$ 22.36 - $ 46.75
1,207,160
na
2.22B
$ 1.14
$ 55.08
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-06-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 10-25-2023 09-30-2023 10-Q
4 07-27-2023 06-30-2023 10-Q
5 04-26-2023 03-31-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 10-26-2022 09-30-2022 10-Q
8 07-27-2022 06-30-2022 10-Q
9 04-27-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-02-2021 09-30-2021 10-Q
12 07-29-2021 06-30-2021 10-Q
13 04-29-2021 03-31-2021 10-Q
14 02-23-2021 12-31-2020 10-K
15 10-29-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 10-25-2019 09-30-2019 10-Q
20 07-25-2019 06-30-2019 10-Q
21 04-29-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 07-26-2018 06-30-2018 10-Q
25 04-26-2018 03-31-2018 10-Q
26 03-01-2018 12-31-2017 10-K
27 10-26-2017 09-30-2017 10-Q
28 07-26-2017 06-30-2017 10-Q
29 04-26-2017 03-31-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 10-28-2016 09-30-2016 10-Q
32 07-28-2016 06-30-2016 10-Q
33 04-27-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-04-2015 09-30-2015 10-Q
36 07-31-2015 06-30-2015 10-Q
37 05-01-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-07-2014 09-30-2014 10-Q
40 08-05-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-maintains-neutral-on-integra-lifesciences-raises-price-target-to-28

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target fro...

 morgan-stanley-maintains-underweight-on-integra-lifesciences-lowers-price-target-to-24

Morgan Stanley analyst Drew Ranieri maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and lowers the price tar...

 jmp-securities-maintains-market-outperform-on-integra-lifesciences-lowers-price-target-to-40

JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...

 wells-fargo-downgrades-integra-lifesciences-to-equal-weight-lowers-price-target-to-25

Wells Fargo analyst Vik Chopra downgrades Integra Lifesciences (NASDAQ:IART) from Overweight to Equal-Weight and lowers the ...

 truist-securities-maintains-hold-on-integra-lifesciences-lowers-price-target-to-25

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price tar...

 b-of-a-securities-maintains-underperform-on-integra-lifesciences-lowers-price-target-to-26

B of A Securities analyst Craig Bijou maintains Integra Lifesciences (NASDAQ:IART) with a Underperform and lowers the price ...

 stocks-on-track-for-third-green-session-palantir-ignites-rally-in-chipmakers-commodities-rebound-whats-driving-markets-monday

The stock market is poised to mark a third consecutive session of gains, with major indices all trading in the green during mid...

 why-is-medical-device-maker-integra-lifesciences-stock-falling-on-monday

Integra LifeSciences surpasses expectations with first-quarter revenues of $368.9 million, reporting growth in Codman Specialty...

 integra-lifesciences-expects-fy24-revenue-of-1672b-1687b-prior-1603b-1618b-vs-1616b-est-adj-eps-of-301-311-prior-315-325-vs-319-est

2024 Outlook For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.672 to $1.687 bil...

 integra-lifesciences-expects-q2-revenue-of-411m-416m-vs-3958m-est-adj-eps-of-060-065-vs-075-est

2024 Outlook For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.672 to $1.687 bil...

 integra-lifesciences-to-spotlight-cerelink-intracranial-pressure-monitoring-system-at-the-american-association-of-neurological-surgeons-annual-scientific-meeting

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is pleased to announce th...

 citigroup-upgrades-integra-lifesciences-to-neutral-maintains-price-target-to-38

Citigroup analyst Joanne Wuensch upgrades Integra Lifesciences (NASDAQ:IART) from Sell to Neutral and maintains the price ta...

 integra-lifesciences-launches-micromatrix-flex-to-provide-convenient-access-to-hard-to-reach-areas-in-complex-cases

Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced MicroMatrix® Flex is now available commercially in the...

 top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-march

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 truist-securities-maintains-hold-on-integra-lifesciences-lowers-price-target-to-41

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price tar...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION